{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T05:09:13Z","timestamp":1734239353333,"version":"3.30.2"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.arteri.2024.10.006","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T13:57:26Z","timestamp":1733925446000},"page":"S18-S24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["Quilomicronemia familiar: nuevas perspectivas"],"prefix":"10.1016","volume":"36","author":[{"given":"Agust\u00edn","family":"Blanco Echevarr\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Ariza Corbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidio","family":"Mu\u00f1iz-Grijalvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9194-495X","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"D\u00edaz-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2024.10.006_bib0165","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/joim.13016","article-title":"Familial chylomicronemia syndrome: An under-recognized cause of severe hypertriglyceridaemia","volume":"287","author":"Baass","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.arteri.2024.10.006_bib0170","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/14779072.2017.1311786","article-title":"The burden of familial chylomicronemia syndrome: Interim results from the IN-FOCUS study","volume":"15","author":"Davidson","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.arteri.2024.10.006_bib0175","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jacl.2018.05.013","article-title":"Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study","volume":"12","author":"Blom","year":"2018","journal-title":"J Clin Lipidol"},{"journal-title":"HST13","article-title":"Volanesorsen for treating familial chylomicronaemia syndrome: Highly specialized technologies guidance","year":"2020","key":"10.1016\/j.arteri.2024.10.006_bib0180"},{"key":"10.1016\/j.arteri.2024.10.006_bib0185","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2020.00455","article-title":"Genetics of hypertriglyceridemia","volume":"11","author":"Dron","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arteri.2024.10.006_bib0190","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.3390\/jcm11154311","article-title":"Identifying patients with familial chylomicronemia syndrome using FCS score-based data mining methods","volume":"11","author":"N\u00e9meth","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.arteri.2024.10.006_bib0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cca.2013.11.025","article-title":"Molecular analysis of chylomicronemia in a clinical laboratory setting: Diagnosis of 13 cases of lipoprotein lipase deficiency","volume":"429","author":"Martin-Campos","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arteri.2024.10.006_bib0200","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jacl.2018.07.013","article-title":"Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society","volume":"12","author":"Ariza","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.arteri.2024.10.006_bib0205","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacl.2018.03.093","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","volume":"12","author":"Hegele","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"Suppl 2","key":"10.1016\/j.arteri.2024.10.006_bib0210","first-page":"1","article-title":"Triglyceride metabolism and classification of hypertriglyceridemias","volume":"33","author":"Ibarretxe","year":"2021","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.arteri.2024.10.006_bib0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1499-3872(14)60033-3","article-title":"Familial chylomicronemia syndrome related chronic pancreatitis: A single-center study","volume":"13","author":"Sisman","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.arteri.2024.10.006_bib0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/2013.jamainternmed.477","article-title":"Hypertriglyceridemia and acute pancreatitis","volume":"173","author":"Murphy","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.arteri.2024.10.006_bib0225","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1001\/jamainternmed.2016.6875","article-title":"Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis","volume":"176","author":"Pedersen","year":"2016","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.arteri.2024.10.006_bib0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MPA.0b013e31816074a1","article-title":"Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia","volume":"37","author":"Lloret Linares","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.arteri.2024.10.006_bib0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.12.019","article-title":"Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia","volume":"283","author":"Paquette","year":"2019","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2024.10.006_bib0240","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jacl.2018.05.013","article-title":"Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study","volume":"12","author":"Blom","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.arteri.2024.10.006_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17512433.2017.1251839","article-title":"Building a better understanding of the burden of disease in familial chylomicronemia syndrome","volume":"10","author":"Ahmad","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.arteri.2024.10.006_bib0250","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/14779072.2017.1372193","article-title":"The burden of familial chylomicronemia s\u00edndrome from the patients\u2019 perspective","volume":"15","author":"Gelrud","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.arteri.2024.10.006_bib0255","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: Its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.arteri.2024.10.006_bib0260","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2018.06.814","article-title":"Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an \u201cFCS score\u201d","volume":"275","author":"Moulin","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2024.10.006_bib0265","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM198905113201906","article-title":"Autoimmune hyperchylomicronemia","volume":"320","author":"Kihara","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2024.10.006_bib0270","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1210\/jc.2011-1113","article-title":"Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome","volume":"96","author":"Ashraf","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arteri.2024.10.006_bib0275","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacl.2018.04.010","article-title":"Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span","volume":"12","author":"Williams","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"Suppl 2","key":"10.1016\/j.arteri.2024.10.006_bib0280","first-page":"75","article-title":"Treatment of chylomicronemia","volume":"33","author":"Navarro Hermoso","year":"2021","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.arteri.2024.10.006_bib0285","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome","volume":"381","author":"Witztum","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2024.10.006_bib0290","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2400201","article-title":"Balance Investigators. Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome","volume":"390","author":"Stroes","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2024.10.006_bib0295","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2409368","article-title":"Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk","author":"Watts","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2024.10.006_bib0300","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.arteri.2024.10.006_bib0305","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s40265-021-01516-y","article-title":"Evinacumab: First approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs."},{"key":"10.1016\/j.arteri.2024.10.006_bib0310","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1016\/j.atherosclerosis.2021.06.901","article-title":"A phase 2 trial of the efficacy and safety of evinacumab in patients with severe hypertriglyceridemia","volume":"331","author":"Rosenson","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2024.10.006_bib0315","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","article-title":"Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: A single-arm, open-label, phase 3 study","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2024.10.006_bib0320","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/jamainternmed.2013.13309","article-title":"Severe hypertriglyceridemia with pancreatitis: Thirteen years\u2019 treatment with lomitapide","volume":"174","author":"Sacks","year":"2014","journal-title":"JAMA Intern Med"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916824001098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916824001098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T09:59:07Z","timestamp":1734170347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916824001098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":32,"alternative-id":["S0214916824001098"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2024.10.006","relation":{},"ISSN":["0214-9168"],"issn-type":[{"type":"print","value":"0214-9168"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quilomicronemia familiar: nuevas perspectivas","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2024.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Arteriosclerosis.","name":"copyright","label":"Copyright"}]}}